We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Low-Cost Portable Sensor Detects Heavy Metals in Sweat

By LabMedica International staff writers
Posted on 24 Jan 2023

Heavy metals like lead and cadmium can be found in batteries, cosmetics, food and many other things that have become a part of daily life. More...

However, they become toxic if they accumulate in the human body and can cause several health problems. Expensive equipment and a controlled laboratory environment are usually required to detect heavy metals in body fluids. Researchers have now developed a portable sensor made of simple materials that can detect heavy metals in sweat, which is easily sampled.

Humans discharge heavy metals mostly through sweat and urine. The analysis of these biofluids forms a key part of toxicological tests as well as treatment. As compared to other gold-standard tests for detecting heavy metals in biofluids, the new sensor developed by researchers at the University of São Paulo (São Paulo, Brazil) is simple in terms of the materials used to manufacture it and the production stages it goes through. The device is connected to a potentiostat, a portable instrument that determines the concentration of each metal by measuring differences in potential and current between electrodes. The result is displayed on a computer or smartphone using appropriate application software. The system is so simple that it can be used by non-specialists without training, as well as by technicians in hospitals, clinics and doctor’s offices.

“We get important information on a person’s health by measuring their exposure to heavy metals. High levels of cadmium can lead to fatal problems in the airways, liver and kidneys. Lead poisoning damages the central nervous system and causes irritability, cognitive impairment, fatigue, infertility, high blood pressure in adults and delayed growth and development in children,” said Paulo Augusto Raymundo Pereira, last author of the article. “The world needs flexible sensors that are easily, cheaply and rapidly mass-produced, as our device is, for on-site detection, continuous monitoring and decentralized analysis of hazardous compounds.”

“The base of the device is polyethylene terephthalate (PET), on top of which is a conductive flexible copper adhesive tape, a label of the kind you can buy from a stationer’s, with the sensor printed on it, and a protective layer of nail varnish or spray,” said Robson R. da Silva, co-author of the article. “The exposed copper is removed by immersion in ferric chloride solution for 20 minutes, followed by washing in distilled water to promote the necessary corrosion. All this ensures speed, scalability, low power and low cost.”

Related Links:
University of São Paulo 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

CAP Updates Cancer Protocols to Refine Breast Cancer Biomarker Reporting and GIST Molecular Testing

Standardized biomarker reporting and molecular profiling are central to pathology-driven cancer care, but evolving practices require laboratories to keep reporting templates current. These templates capture... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.